- Title
- Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube, and peritoneal cancers
- Creators
- J.S. Ferriss - Temple UniversityJ. Java - Gynecologic Oncology GroupR.A. Burger - University of PennsylvaniaM.A. Bookman - University of ArizonaG. Fleming - University of Chicago Medical CenterB.J. Monk - University of ArizonaJ.L. Walker - University of OklahomaH.D. Homesley - East Carolina UniversityJ.M. Fowler - The Ohio State UniversityB.E. Greer - University of Washington Medical CenterM.P. Boente - Minnesota Oncology
- Publication Details
- Gynecologic oncology, Vol.133, pp.25-25
- Publisher
- Elsevier Inc
- Identifiers
- 991005968800802656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube, and peritoneal cancers
Gynecologic oncology, Vol.133, pp.25-25
06/2014
Metrics
1 Record Views